Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Atai Life Sciences N.V. (NQ: ATAI ) 1.070 -0.020 (-1.83%) Streaming Delayed Price Updated: 12:47 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 409,394 Open 1.100 Bid (Size) 1.070 (41) Ask (Size) 1.080 (68) Prev. Close 1.090 Today's Range 1.060 - 1.109 52wk Range 1.025 - 2.850 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week September 15, 2024 The psychedelic compound-based drug market is expected to triple over the next few years, creating many winning stocks in the years to come. Via Talk Markets MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward? September 12, 2024 Via Benzinga Exposures Product Safety Performance YTD -36.69% -36.69% 1 Month -12.30% -12.30% 3 Month -16.41% -16.41% 6 Month -55.23% -55.23% 1 Year -23.02% -23.02% More News Read More Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th September 10, 2024 Via Talk Markets Our Psychedelic Compound-Based Clinical-Stage Drug Stocks Portfolio Was Down 16% In August September 06, 2024 Via Talk Markets Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration September 05, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From atai Life Sciences Via GlobeNewswire Largest Psychedelic Compound -Based Clinical-Stage Drug Stocks Up 6% Last Week August 24, 2024 Via Talk Markets Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD August 15, 2024 Via Talk Markets Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant August 14, 2024 Via Benzinga ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024 August 13, 2024 Via InvestorPlace atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates August 13, 2024 From atai Life Sciences Via GlobeNewswire atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT) August 13, 2024 From atai Life Sciences Via GlobeNewswire atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference August 07, 2024 From atai Life Sciences Via GlobeNewswire EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves July 31, 2024 Via Benzinga Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets 3 Dirt-Cheap Drug Developers With Blockbuster Potential July 11, 2024 Via InvestorPlace 3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers July 08, 2024 Via InvestorPlace 3 Psychedelic Stocks to Ride to the Moon and Beyond July 06, 2024 Via InvestorPlace Exposures Product Safety Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns July 03, 2024 Via InvestorPlace 3 Psychedelic Stocks to Buy on the Dip: Summer 2024 July 02, 2024 Via InvestorPlace Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Via Talk Markets atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference June 26, 2024 From atai Life Sciences Via GlobeNewswire Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Via Talk Markets atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a June 20, 2024 From atai Life Sciences Via GlobeNewswire Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why June 09, 2024 Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
